RITUXIMAB-PVVR for Multiple sclerosis: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 106 adverse event reports in the FDA FAERS database where RITUXIMAB-PVVR was used for Multiple sclerosis.
Most Reported Side Effects for RITUXIMAB-PVVR
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 2,079 | 49.4% | 209 | 502 |
| Intentional product use issue | 627 | 14.9% | 56 | 146 |
| Condition aggravated | 514 | 12.2% | 26 | 147 |
| Death | 338 | 8.0% | 338 | 63 |
| Covid-19 | 322 | 7.7% | 39 | 135 |
| Fatigue | 318 | 7.6% | 15 | 84 |
| Dyspnoea | 314 | 7.5% | 27 | 104 |
| Inappropriate schedule of product administration | 311 | 7.4% | 21 | 77 |
| Headache | 291 | 6.9% | 8 | 77 |
| Pruritus | 288 | 6.8% | 4 | 35 |
| Nausea | 286 | 6.8% | 8 | 76 |
| Malaise | 275 | 6.5% | 28 | 95 |
| Pain | 271 | 6.4% | 13 | 79 |
| Throat irritation | 259 | 6.2% | 1 | 30 |
| Cough | 249 | 5.9% | 15 | 64 |
Other Indications for RITUXIMAB-PVVR
Rheumatoid arthritis (1,659)
Granulomatosis with polyangiitis (745)
Microscopic polyangiitis (174)
Systemic lupus erythematosus (105)
Interstitial lung disease (73)
Glomerulonephritis membranous (65)
Anti-neutrophil cytoplasmic antibody positive vasculitis (62)
Sjogren's syndrome (54)
Product used for unknown indication (52)
Pemphigus (51)
Other Drugs Used for Multiple sclerosis
DIMETHYL (78,567)
NATALIZUMAB (56,733)
INTERFERON BETA-1A (56,475)
FINGOLIMOD (43,123)
TERIFLUNOMIDE (29,963)
DALFAMPRIDINE (28,787)
GLATIRAMER (27,144)
OCRELIZUMAB (15,501)
OFATUMUMAB (11,816)
PEGINTERFERON BETA-1A (11,105)